Healthcare • Biotechnology
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if QNTM is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
7 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
26 filers reported a long position in QNTM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| AdvisorShares Investments LLC | $736.9K | 203.6K | +87.5% |
| JANE STREET GROUP, LLC | $175K | 48.4K | +53.5% |
| Platform Technology Partners | $148.8K | 41.1K | Unchanged |
| UBS Group AG | $120.9K | 33.4K | +361.6% |
| Steward Partners Investment Advisory, LLC | $100.9K | 27.9K | +536.4% |
| CITADEL ADVISORS LLC | $57.4K | 15.9K | Unchanged |
| Marex Group Ltd | $48.6K | 13.4K | -0.2% |
| Mariner, LLC | $36.2K | 10K | -0.6% |
| LANARK FINANCIAL, INC. | $25.3K | 7K | New |
| OSAIC HOLDINGS, INC. | $22.8K | 6.3K | -1.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.